CHARLESTON, W.Va. (WSAZ) - The municipal auditorium in downtown Charleston has been closed for nearly a year due to health and safety reasons. Mayor Amy Goodwin said the city is taking the next ...

Rachael Hood, Senior Editor There's no better place to start absorbing Nashville's musical heritage than the Ryman Auditorium. It's no longer home to the Grand Ole Opry, but the venue continues to ...

Overview: CSPC Pharmaceutical Group Limited is an investment holding company involved in the research, development, manufacture, and sale of pharmaceutical products across China and ...

The pipe organ was named in honor of St. Augustine philanthropist Dr. Andrew Anderson, who in 1924 saw the beauty of the newly constructed University Auditorium on the UF campus and donated $ ...

On Friday evening, the Grand Ole Opry kicked off its next century of broadcasts with a star-studded three-hour event at Lower Broadway's Ryman Auditorium, one of its former homes. Opry cast ...

Overview: CSPC Pharmaceutical Group Limited is an investment holding company involved in the research, development, manufacture, and sale of pharmaceutical products across China and internationally, ...

This advancement positions CSPC as a significant player in addressing unmet medical needs in the oncology sector. For further insights into HK:1093 stock, check out TipRanks’ Stock Analysis page.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

China National Offshore Oil Corporation (CNOOC) and Shell plc's joint venture, CNOOC and Shell Petrochemicals Company Limited (CSPC), announced Wednesday they would invest in the Huizhou Phase III ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

AstraZeneca has joined the ranks of pharma companies seeking to bring drugs targeting lipoprotein(a) to market, paying $100 million upfront for rights to a drug developed by CSPC Pharmaceutical.